For people managing HIV alongside a history of injection drug use, the COVID-19 pandemic introduced a uniquely compounded threat — not just a viral one, but a psychosocial and behavioral one. Understanding how extreme stress reshapes substance use patterns in already-vulnerable populations has direct implications for designing resilient treatment programs capable of withstanding future public health crises.
This mixed-methods secondary analysis drew on survey and qualitative interview data from 132 people living with HIV and a history of injection drug use in Russia, collected across two clinical trials between May 2020 and July 2021. Just over half of participants reported high financial worry linked to the pandemic, while nearly a third reported high pandemic-related stress. Approximately one in five participants reported any change in illicit opioid use during this period, with the vast majority of those changes representing decreases rather than increases. Critically, high pandemic stress was independently associated with nearly a threefold increase in the odds of reporting any opioid use change (adjusted odds ratio 2.98; 95% CI: 1.20–7.40). Financial worry showed a directionally similar but statistically imprecise association. Cigarette and alcohol use changes showed no significant associations with either stress or financial worry.
Several layers of nuance deserve attention here. The cohort is small and geographically specific — Russia during the pandemic represents a distinct social, economic, and policy environment, including highly restrictive drug treatment access, which limits generalizability. The finding that most opioid use changes reflected decreases, not increases, challenges the intuitive assumption that stress universally drives escalation; supply-side disruptions and fear-driven avoidance of drug markets likely contributed. The mixed-methods design strengthens credibility by triangulating quantitative associations with qualitative lived experience. Still, this is secondary analysis with a modest sample, and causal inference remains impossible. For researchers and clinicians, the core signal — that psychological stress is a stronger predictor of behavioral disruption than financial hardship alone — may inform targeted stress-reduction interventions within HIV care programs, particularly in anticipation of future crises.